HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 1001 | 1186 | 84.4% | |
| HF 4 | 2012 | 1136 | 1333 | 85.2% | |
| HF 4 | 2013 | 1192 | 1361 | 87.6% | |
| HF004 | 2014 | 864 | 951 | 90.8% | |
| HF004 | 2015 | 909 | 974 | 93.3% | |
| HF004 | 2016 | 1130 | 1181 | 95.7% | |
| HF004 | 2017 | 1299 | 1386 | 93.7% | |
| HF004 | 2018 | 1361 | 1450 | 93.9% | |
| HF004 | 2019 | 1574 | 1719 | 91.6% | |
| HF004 | 2020 | 1617 | 1745 | 92.7% | |
| HF006 | 2021 | 2080 | 2247 | 92.6% | |
| HF006 | 2022 | 2363 | 2472 | 95.6% | |
| HF006 | 2023 | 2744 | 2810 | 97.7% |
